Beyond its skeletal effects, MM has been shown to remodel the bone marrow niche by promoting a persistent inflammatory state in MSCs, marked by elevated expression of IL6, LIF, and IL1R1 [12,21]. The gene discussed is IL1R1; the disease is Miyoshi myopathy.